Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
about
Role of HIV in amyloid metabolismHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsCellular Interactions and Signaling in neuroAIDS: Emerging Issues ColloquiumNew insights into immune reconstitution inflammatory syndrome of the central nervous system.The impact of HIV-1 on neurogenesis: implications for HANDCombination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy.Antiretroviral therapy reduces neurodegeneration in HIV infectionIdentification of lncRNA expression profile in the spinal cord of mice following spinal nerve ligation-induced neuropathic pain.HIV-Tat Induces the Nrf2/ARE Pathway through NMDA Receptor-Elicited Spermine Oxidase Activation in Human Neuroblastoma Cells.Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.Caspase-dependent degradation of MDMx/MDM4 cell cycle regulatory protein in amyloid β-induced neuronal damage.Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic DamageHIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance.SAMHD1 transcript upregulation during SIV infection of the central nervous system does not associate with reduced viral load.Enhanced antagonism of BST-2 by a neurovirulent SIV envelopeInvestigational protease inhibitors as antiretroviral therapies.Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free ChildrenNeuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND.Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies.An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response.In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals.Astrocyte Elevated Gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.Treating HIV Infection in the Central Nervous System.Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patientsThe Role of HIV Infection in Neurologic Injury.Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling.Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity.HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.Subjective memory complaints are associated with poorer cognitive performance in adults with HIV.An SIV/macaque model targeted to study HIV-associated neurocognitive disorders.Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro.Piperine ameliorates SCA17 neuropathology by reducing ER stress.
P2860
Q26824179-A8299FBA-650C-4F80-8DE8-6F8080AC83BFQ28392199-C18E45BB-C51C-4140-9BEA-09EBDB56D11CQ33925534-9DB7CC1B-8D99-4F0E-A84E-4EC9E883033CQ34433828-91E47258-BE97-458D-B1EF-1E65E69222B5Q34472345-DFF874E8-F40B-4033-8FA0-A24610C16062Q34714277-C08C22FE-9570-4783-A457-F3942ADD7AB6Q35064192-49D6EB43-5055-4F12-B74C-F52A4B37E01AQ35159221-5FB498C8-8261-4A17-9060-BFA9700DE057Q35857680-701478FA-B4B2-4F0F-87E6-A21D5BD6F5FAQ35928708-9446C1D7-28CC-42F2-8038-19A4D2502B69Q35984276-A05008C1-7FE9-4D95-98DB-88E1FBEBE095Q36169735-5179BFFB-B7C0-4A65-A2F0-D1329EBBA9D6Q36293999-198B30BB-AE25-4C08-8A9F-32F7D4A9FE44Q36372974-3545D9C1-F42A-47CB-A6B3-AD59948CEE5CQ36439056-2B4A6028-2B96-49AF-8275-DAC2294FBABAQ36517668-4B1381A6-0C6C-455F-A194-566A9E7F51EFQ36645459-C1621E09-3517-43E6-BDEC-EDC6E81AD992Q36951741-975B5042-CEB2-4381-88A0-4107F780EEB7Q37582521-F3028681-B6BE-4743-96A8-17EC2B2FDC02Q37691000-AA6E4338-0C70-4129-9664-B81CC08B4D7EQ37721505-64F8F15F-46E2-4B45-9E35-8C32FF80FD51Q38247035-5C777EF8-16F2-482C-B6CE-191725B77144Q38444808-5096280F-37A6-44EF-89ED-50C4105D3D1DQ38628801-09E218FC-2031-4FE0-94B9-5749E169CC49Q38634561-6637B1BC-9C50-4D2D-A388-C6D7F194AD71Q38645161-66DCAA5A-D440-4657-891F-7971AAFBA6BCQ38811225-B96D48E9-F42E-4753-AF51-814C4BCA048CQ38882614-7739D3B9-2B51-4099-809B-18900989643CQ39077816-23E4740F-549F-4979-B199-DA1BCE37C86EQ39116610-67188D82-D8AD-4A8B-BBC5-EF74ADEBE0B2Q39224160-5623EB44-293C-40AB-80F8-3D76512822E5Q39979692-89E0D7EC-E4B3-4B2A-99D1-21DCDE4B908AQ40147390-E9E5FDA0-57E4-478E-9C39-64BED52E87D1Q40296944-0475BF5F-F905-4EB3-8F24-48269CB57770Q40404098-64AB5A90-CA69-4DD7-940A-826452174EBBQ40468806-50D0096A-35D7-406E-B606-A61E00BDF013Q41924980-F83D81C0-C68E-4834-BFB7-0C50E9A8350AQ42203691-26382C12-9C81-4747-8A9F-5464BDE4CD4DQ47107234-405201E5-419C-4753-841E-B8888539B56FQ48148566-C5E2A43C-90CE-4E41-B879-887BE13644CB
P2860
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiretroviral drugs induce ox ...... in the central nervous system
@en
Antiretroviral drugs induce ox ...... in the central nervous system.
@nl
type
label
Antiretroviral drugs induce ox ...... in the central nervous system
@en
Antiretroviral drugs induce ox ...... in the central nervous system.
@nl
prefLabel
Antiretroviral drugs induce ox ...... in the central nervous system
@en
Antiretroviral drugs induce ox ...... in the central nervous system.
@nl
P2093
P2860
P50
P1476
Antiretroviral drugs induce ox ...... in the central nervous system
@en
P2093
Akinleye Odeleye
Alison M Buch
Brigid K Jensen
Denise R Cook
Dennis L Kolson
Emily S Andersen
Jamie L Dorsey
Janice Clements
Joseph Mankowski
Kathryn A Lindl
P2860
P2888
P356
10.1007/S13365-013-0227-1
P577
2014-01-14T00:00:00Z